Fig. 1. Changes of hematologic parameters during one-year eliglustat therapy: hemoglobin concentration (A) and platelet count (B).

Journal of Genetic Medicine 2020;17:62-7 https://doi.org/10.5734/JGM.2020.17.2.62

© 2020 Korean Society of Medical Genetics and Genomics